Rob McAveneyCTO, ArasLatest in HomeSponsoredWhy Biocompatibility Plans Should Focus on Storytelling, Not Data DumpingApril 9, 2026Parasol Secures $2.75M for Medical Device to Improve Stroke PreventionOctober 28, 2026Empatica Launches FDA-Cleared Parkinson's Monitoring Device for Home UseOctober 28, 2026Blue Arbor Raises $10.5M for Prosthetic Controlling DeviceOctober 28, 2026Related StoriesHome5 Things We Know and Still Don't Know about COVID, 5 Years After it AppearedHomeQ&A: How to Attract Gen Z to Manufacturing Through Authentic StorytellingHomeDriving Quality Control Excellence with MOM IntegrationSponsor ContentWhy Biocompatibility Plans Should Focus on Storytelling, Not Data Dumping
